In This Story NVO LLY Novo Nordisk ( NVO ) CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for the blockbuster drugs Ozempic and Wegovy, the company said Friday. Suggested Reading Microsoft says it would sell Office without Teams to get Europe off its back Forget trade talks: Trump says the U.S. will just tell countries their tariff rates (again) Walmart helped keep America's prices low for decades. Now it's leading them